Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

110.17USD
1 Jul 2016
Change (% chg)

$0.88 (+0.81%)
Prev Close
$109.29
Open
$109.71
Day's High
$110.20
Day's Low
$108.89
Volume
355,337
Avg. Vol
637,433
52-wk High
$110.68
52-wk Low
$64.03

Termeer, Henri 

Mr. Henri A. Termeer is an Independent Director of Abiomed Inc., since May 1987. Prior to Genzyme Corporation’s acquisition in April 2011 by Sanofi, Mr. Termeer had been the President, and a director of Genzyme Corporation since 1983, its Chief Executive Officer since 1985 and its Chairman since 1988. Mr. Termeer is a member of the Board of Directors of the Massachusetts Institute of Technology, Massachusetts General Hospital and Partners HealthCare. Mr. Termeer is a member of the Board of Fellows of Harvard Medical School. He is also the Chairman of the Board of Aveo Pharmaceuticals and member of the Board of Directors of Verastem, Inc. Mr. Termeer served as the Deputy Chairman of the Federal Reserve Bank of Boston from 2007 to 2009 and as its Chairman from 2010 through the end of 2011. Mr. Termeer studied economics at the Economische Hogeschool at Erasmus University in The Netherlands and received his Master of Business Administration from the Darden School of Business at the University of Virginia.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Minogue

5,393,450

Michael Tomsicek

--

David Weber

1,438,480

William Bolt

1,291,870

Andrew Greenfield

536,074

Michael Howley

1,136,130
As Of  30 Mar 2015